In an innovative move to transform research into menopause, Research Smart, a leader in healthcare research technology, has joined forces with genetic profiling pioneer EndoDNA to develop AI-enabled research tools to help women manage the symptoms of menopause. This strategic partnership marks a significant step, combining advanced genetic insights with real-time user feedback to refine and personalize health solutions for the 47m women around the world who enter menopause each year.

Menopause, a process of ovarian aging when hormone production declines and a woman ceases to have periods, is projected to affect over 1.2 billion women by 2030. About 80% of women will experience vasomotor symptoms such as hot flashes, night sweats, anxiety, and sleep disturbances at some point. Despite current research, stigma and misconceptions about menopause are still widespread. Alarmingly, 9 in 10 women have not been educated about menopause, and 60% only start looking for information once their symptoms begin.

Recent research shows that 49% of women in the UK and 75% in the US do not consider Hormone Replacement Therapy (HRT) as their first option, preferring nutrition and supplements instead. However, the supplements industry often lacks transparency, leaving many women unclear about which products to trust and which are appropriate for them.
EndoDNA, known for its cutting-edge approach to precision wellness, focuses on providing individualized product recommendations and treatment plans based on genetic profiles. In collaboration with LA’s Top Menopause & Sexual Health Expert and NY Times Best Selling Author, Dr Jennifer R. Berman, EndoDNA has developed the Menopause Biotype DNA test. This test helps women understand their potential for menopausal symptoms and risks, enabling them to better prepare for bodily changes, manage symptoms more effectively, and mitigate the development of associated conditions stemming from changes in estrogen and/or androgen levels.

Every woman’s experience with menopause is distinct, with no two Menopause Biotypes being identical. Each woman faces varying degrees of risks and symptoms, including hot flashes, mood swings, sleep disturbances, weight fluctuations, fatigue, joint discomfort, short-term memory loss, diminished desire, urinary frequency/urgency, and vaginal dryness. By identifying a woman’s Menopause Biotype, it is possible to gain insights into expected symptoms and potential severity, potentially preemptively addressing risks and managing bodily changes. The Menopause Biotype empowers women to be proactive about their menopausal health and enables healthcare providers to prescribe appropriate hormonal treatments with greater confidence.

The partnership will integrate EndoDNA’s genetic profiling tools with Research Smart’s mobile application technology, enabling real-time data collection and participant monitoring. This synergy will improve the accuracy of health recommendations based on genetic markers and allow continuous refinement of these suggestions based on user feedback and outcomes.
Dr. Jen Berman, creator of the Menopause Biotype, said, “My mission is to advocate for and empower women through their menopause journey. I’m delighted to see the strategic collaboration between EndoDNA and Research Smart to foster better health outcomes for women.”

Len May, CEO of EndoDNA, commented on the partnership, stating, “We are thrilled to partner with Dr. Jen Berman and Research Smart to push the boundaries of precision wellness. By combining our genetic profiling technology with Research Smart’s innovative platform, we can complete the ‘feedback loop’ and offer customers an iterative path towards their optimal personalized medicine experience. Together, we are setting a new standard for how individuals receive and respond to health and wellness advice tailored specifically to their DNA.”

Gavin Sathianathan, CEO of Research Smart, added, “Our collaboration with EndoDNA and Dr Jen Berman represents a step forwards in empowering women in the menopause. I believe that this approach to precision wellness will become a feature of many other areas of women’s health in the near future, representing a paradigm shift in the quality of life of women around the world.”

Source URL : https://www.openpr.com/news/3593507/research-smart-and-endodna-announce-strategic-collaboration